Literature DB >> 3925547

Hormone binding globulins and anticonvulsant therapy.

G H Beastall, R A Cowan, J M Gray, I Fogelman.   

Abstract

Serum sex hormone binding globulin, thyroxine binding globulin, cortisol binding globulin and vitamin D binding globulin, together with total levels of the appropriate bound hormones, were determined in 21 epileptic subjects who had been stabilised by long-term anticonvulsant therapy. Serum sex hormone binding globulin capacity was higher in these patients than in appropriate control groups (men p less than 0.05; women p less than 0.01), and values correlated with serum phenytoin levels in the female subjects (p less than 0.01). Thyroxine binding globulin levels were unaffected by anticonvulsants, but significant reductions in serum thyroxine (men p less than 0.05; women p less than 0.001) and triiodothyronine (men p less than 0.05; women p less than 0.01) were observed. Cortisol binding globulin capacity was appreciably elevated in patients of either sex (p less than 0.001), and in the women this was accompanied by a reduction in serum cortisol (p less than 0.001) and a significant correlation with the serum phenytoin concentration (p less than 0.01). Neither vitamin D binding globulin capacity nor serum 25-hydroxycholecalciferol levels were influenced by anticonvulsants in this study. It is concluded that anticonvulsant drug therapy causes widespread alterations in the normal homeostasis between hormones and their serum binding globulins. Such alterations may well have clinical significance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3925547     DOI: 10.1177/003693308503000206

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  5 in total

Review 1.  Neuroendocrine considerations in the treatment of men and women with epilepsy.

Authors:  Cynthia L Harden; Page B Pennell
Journal:  Lancet Neurol       Date:  2013-01       Impact factor: 44.182

Review 2.  Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy.

Authors:  Jouko I T Isojärvi; Erik Taubøll; Andrew G Herzog
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 3.  Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management.

Authors:  J Bauer; J I T Isojärvi; A G Herzog; M Reuber; D Polson; E Taubøll; P Genton; H van der Ven; B Roesing; G J Luef; C A Galimberti; J van Parys; D Flügel; A Bergmann; C E Elger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-08       Impact factor: 10.154

Review 4.  [Which antiepileptic drug for men with epilepsy? A critical epileptological and andrological review].

Authors:  J Bauer; D Klingmüller
Journal:  Nervenarzt       Date:  2008-12       Impact factor: 1.214

Review 5.  Special Considerations in the Management of Women with Epilepsy in Reproductive Years.

Authors:  Krishna Parekh; Hannah Debra Kravets; Rebecca Spiegel
Journal:  J Pers Med       Date:  2022-01-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.